Stockreport

Jasper Therapeutics Appoints Jeet Mahal as Chief Executive Officer to Lead Next Phase of Clinical Growth

Jasper Therapeutics, Inc. - Class A  (JSPR) 
PDF Thomas Wiggans appointed Executive Chairperson  Jasper to host an investor webinar on January 8th at 8:00am ET to present updated data from the BEACON study in CSU and [Read more]